Please provide your email address to receive an email when new articles are posted on . Subcutaneous navenibart was given as either 600 mg then 300 mg every 3 months or 600 mg every 6 months. Both ...

Please provide your email address to receive an email when new articles are posted on . The mean attack rate at baseline was 2.18, and this dropped to 0.12 in the open-label extension study. There was ...